nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP2D6—Fingolimod—multiple sclerosis	0.115	0.189	CbGbCtD
Lercanidipine—CYP3A4—Fingolimod—multiple sclerosis	0.073	0.12	CbGbCtD
Lercanidipine—CYP3A7—Dexamethasone—multiple sclerosis	0.0608	0.1	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0608	0.1	CbGbCtD
Lercanidipine—CYP3A4—Methylprednisolone—multiple sclerosis	0.047	0.0775	CbGbCtD
Lercanidipine—CYP3A5—Dexamethasone—multiple sclerosis	0.0456	0.0752	CbGbCtD
Lercanidipine—CYP3A4—Triamcinolone—multiple sclerosis	0.0357	0.0587	CbGbCtD
Lercanidipine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0343	0.0565	CbGbCtD
Lercanidipine—CYP3A4—Betamethasone—multiple sclerosis	0.0306	0.0504	CbGbCtD
Lercanidipine—CYP3A4—Prednisolone—multiple sclerosis	0.0302	0.0497	CbGbCtD
Lercanidipine—CYP3A4—Prednisone—multiple sclerosis	0.0285	0.0469	CbGbCtD
Lercanidipine—CYP2D6—Dexamethasone—multiple sclerosis	0.028	0.0461	CbGbCtD
Lercanidipine—CYP3A4—Dexamethasone—multiple sclerosis	0.0178	0.0293	CbGbCtD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00109	0.0526	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM1 interactions—PRNP—multiple sclerosis	0.000728	0.0352	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM1 interactions—PRNP—multiple sclerosis	0.00064	0.0309	CbGpPWpGaD
Lercanidipine—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.000447	0.0216	CbGpPWpGaD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000443	0.0214	CbGpPWpGaD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000443	0.0214	CbGpPWpGaD
Lercanidipine—CYP3A7—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000437	0.0211	CbGpPWpGaD
Lercanidipine—CYP3A7—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000437	0.0211	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.000428	0.0207	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.000376	0.0182	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—CD24—multiple sclerosis	0.000372	0.018	CbGpPWpGaD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000359	0.0174	CbGpPWpGaD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000359	0.0174	CbGpPWpGaD
Lercanidipine—Discomfort—Methylprednisolone—multiple sclerosis	0.000357	0.000958	CcSEcCtD
Lercanidipine—Headache—Azathioprine—multiple sclerosis	0.000356	0.000957	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000356	0.000957	CcSEcCtD
Lercanidipine—Dry mouth—Triamcinolone—multiple sclerosis	0.000354	0.000951	CcSEcCtD
Lercanidipine—Renal failure—Methotrexate—multiple sclerosis	0.000353	0.000948	CcSEcCtD
Lercanidipine—Angioedema—Betamethasone—multiple sclerosis	0.000352	0.000947	CcSEcCtD
Lercanidipine—Angioedema—Dexamethasone—multiple sclerosis	0.000352	0.000947	CcSEcCtD
Lercanidipine—Stomatitis—Methotrexate—multiple sclerosis	0.00035	0.00094	CcSEcCtD
Lercanidipine—Angiopathy—Prednisone—multiple sclerosis	0.00035	0.00094	CcSEcCtD
Lercanidipine—Confusional state—Methylprednisolone—multiple sclerosis	0.000349	0.000937	CcSEcCtD
Lercanidipine—Immune system disorder—Prednisone—multiple sclerosis	0.000348	0.000936	CcSEcCtD
Lercanidipine—Malaise—Betamethasone—multiple sclerosis	0.000348	0.000934	CcSEcCtD
Lercanidipine—Malaise—Dexamethasone—multiple sclerosis	0.000348	0.000934	CcSEcCtD
Lercanidipine—Vertigo—Betamethasone—multiple sclerosis	0.000346	0.000931	CcSEcCtD
Lercanidipine—Vertigo—Dexamethasone—multiple sclerosis	0.000346	0.000931	CcSEcCtD
Lercanidipine—Syncope—Dexamethasone—multiple sclerosis	0.000346	0.000929	CcSEcCtD
Lercanidipine—Syncope—Betamethasone—multiple sclerosis	0.000346	0.000929	CcSEcCtD
Lercanidipine—Shock—Triamcinolone—multiple sclerosis	0.000341	0.000917	CcSEcCtD
Lercanidipine—Insomnia—Prednisolone—multiple sclerosis	0.000341	0.000916	CcSEcCtD
Lercanidipine—Alopecia—Prednisone—multiple sclerosis	0.000341	0.000916	CcSEcCtD
Lercanidipine—Shock—Methylprednisolone—multiple sclerosis	0.00034	0.000915	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00034	0.000913	CcSEcCtD
Lercanidipine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000339	0.000912	CcSEcCtD
Lercanidipine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000339	0.000911	CcSEcCtD
Lercanidipine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000339	0.000911	CcSEcCtD
Lercanidipine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000339	0.00091	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisolone—multiple sclerosis	0.000339	0.00091	CcSEcCtD
Lercanidipine—Tachycardia—Triamcinolone—multiple sclerosis	0.000338	0.000909	CcSEcCtD
Lercanidipine—Mental disorder—Prednisone—multiple sclerosis	0.000338	0.000908	CcSEcCtD
Lercanidipine—Nausea—Azathioprine—multiple sclerosis	0.000338	0.000908	CcSEcCtD
Lercanidipine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000338	0.000907	CcSEcCtD
Lercanidipine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000336	0.000903	CcSEcCtD
Lercanidipine—Malnutrition—Prednisone—multiple sclerosis	0.000336	0.000902	CcSEcCtD
Lercanidipine—Erythema—Prednisone—multiple sclerosis	0.000336	0.000902	CcSEcCtD
Lercanidipine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000335	0.000901	CcSEcCtD
Lercanidipine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000335	0.0009	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000334	0.000899	CcSEcCtD
Lercanidipine—Asthenia—Mitoxantrone—multiple sclerosis	0.00033	0.000886	CcSEcCtD
Lercanidipine—Myalgia—Dexamethasone—multiple sclerosis	0.000328	0.000882	CcSEcCtD
Lercanidipine—Myalgia—Betamethasone—multiple sclerosis	0.000328	0.000882	CcSEcCtD
Lercanidipine—Anxiety—Betamethasone—multiple sclerosis	0.000327	0.000879	CcSEcCtD
Lercanidipine—Anxiety—Dexamethasone—multiple sclerosis	0.000327	0.000879	CcSEcCtD
Lercanidipine—CACNA1C—Axon guidance—CD24—multiple sclerosis	0.000327	0.0158	CbGpPWpGaD
Lercanidipine—Discomfort—Dexamethasone—multiple sclerosis	0.000324	0.000871	CcSEcCtD
Lercanidipine—Discomfort—Betamethasone—multiple sclerosis	0.000324	0.000871	CcSEcCtD
Lercanidipine—Hypotension—Methylprednisolone—multiple sclerosis	0.000323	0.000869	CcSEcCtD
Lercanidipine—Hepatitis—Methotrexate—multiple sclerosis	0.000322	0.000866	CcSEcCtD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00032	0.0155	CbGpPWpGaD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00032	0.0155	CbGpPWpGaD
Lercanidipine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000318	0.000855	CcSEcCtD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000318	0.0154	CbGpPWpGaD
Lercanidipine—Vision blurred—Prednisone—multiple sclerosis	0.000316	0.00085	CcSEcCtD
Lercanidipine—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000316	0.0153	CbGpPWpGaD
Lercanidipine—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000316	0.0153	CbGpPWpGaD
Lercanidipine—Urethral disorder—Methotrexate—multiple sclerosis	0.000316	0.000849	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000316	0.000849	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000315	0.000847	CcSEcCtD
Lercanidipine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000314	0.000845	CcSEcCtD
Lercanidipine—Insomnia—Triamcinolone—multiple sclerosis	0.000314	0.000843	CcSEcCtD
Lercanidipine—Insomnia—Methylprednisolone—multiple sclerosis	0.000313	0.000841	CcSEcCtD
Lercanidipine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000311	0.000837	CcSEcCtD
Lercanidipine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000311	0.000837	CcSEcCtD
Lercanidipine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000311	0.000835	CcSEcCtD
Lercanidipine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000311	0.000835	CcSEcCtD
Lercanidipine—Anaemia—Prednisone—multiple sclerosis	0.00031	0.000834	CcSEcCtD
Lercanidipine—Shock—Dexamethasone—multiple sclerosis	0.000309	0.000832	CcSEcCtD
Lercanidipine—Shock—Betamethasone—multiple sclerosis	0.000309	0.000832	CcSEcCtD
Lercanidipine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000309	0.000831	CcSEcCtD
Lercanidipine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000308	0.000829	CcSEcCtD
Lercanidipine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000308	0.000829	CcSEcCtD
Lercanidipine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000308	0.000828	CcSEcCtD
Lercanidipine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000308	0.000828	CcSEcCtD
Lercanidipine—Tachycardia—Betamethasone—multiple sclerosis	0.000307	0.000825	CcSEcCtD
Lercanidipine—Tachycardia—Dexamethasone—multiple sclerosis	0.000307	0.000825	CcSEcCtD
Lercanidipine—Angioedema—Prednisone—multiple sclerosis	0.000307	0.000824	CcSEcCtD
Lercanidipine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000305	0.00082	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000305	0.000819	CcSEcCtD
Lercanidipine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000305	0.000818	CcSEcCtD
Lercanidipine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000304	0.000817	CcSEcCtD
Lercanidipine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000304	0.000817	CcSEcCtD
Lercanidipine—Malaise—Prednisone—multiple sclerosis	0.000303	0.000814	CcSEcCtD
Lercanidipine—Vertigo—Prednisone—multiple sclerosis	0.000302	0.000811	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—multiple sclerosis	0.000301	0.000809	CcSEcCtD
Lercanidipine—Syncope—Prednisone—multiple sclerosis	0.000301	0.000809	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—multiple sclerosis	0.0003	0.000808	CcSEcCtD
Lercanidipine—Anorexia—Dexamethasone—multiple sclerosis	0.0003	0.000806	CcSEcCtD
Lercanidipine—Anorexia—Betamethasone—multiple sclerosis	0.0003	0.000806	CcSEcCtD
Lercanidipine—Urticaria—Prednisolone—multiple sclerosis	0.000299	0.000805	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000299	0.000804	CcSEcCtD
Lercanidipine—Fatigue—Triamcinolone—multiple sclerosis	0.000299	0.000803	CcSEcCtD
Lercanidipine—Fatigue—Methylprednisolone—multiple sclerosis	0.000298	0.000802	CcSEcCtD
Lercanidipine—Loss of consciousness—Prednisone—multiple sclerosis	0.000295	0.000793	CcSEcCtD
Lercanidipine—Hypotension—Dexamethasone—multiple sclerosis	0.000294	0.00079	CcSEcCtD
Lercanidipine—Hypotension—Betamethasone—multiple sclerosis	0.000294	0.00079	CcSEcCtD
Lercanidipine—Angiopathy—Methotrexate—multiple sclerosis	0.000292	0.000786	CcSEcCtD
Lercanidipine—Vomiting—Mitoxantrone—multiple sclerosis	0.000292	0.000785	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—multiple sclerosis	0.000291	0.000782	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00029	0.000781	CcSEcCtD
Lercanidipine—Rash—Mitoxantrone—multiple sclerosis	0.00029	0.000779	CcSEcCtD
Lercanidipine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000289	0.000778	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.000289	0.014	CbGpPWpGaD
Lercanidipine—Headache—Mitoxantrone—multiple sclerosis	0.000288	0.000774	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000287	0.00077	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000287	0.00077	CcSEcCtD
Lercanidipine—Arthralgia—Prednisone—multiple sclerosis	0.000286	0.000768	CcSEcCtD
Lercanidipine—Myalgia—Prednisone—multiple sclerosis	0.000286	0.000768	CcSEcCtD
Lercanidipine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000286	0.000768	CcSEcCtD
Lercanidipine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000285	0.000766	CcSEcCtD
Lercanidipine—Anxiety—Prednisone—multiple sclerosis	0.000285	0.000765	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—multiple sclerosis	0.000285	0.000765	CcSEcCtD
Lercanidipine—Insomnia—Betamethasone—multiple sclerosis	0.000285	0.000765	CcSEcCtD
Lercanidipine—Insomnia—Dexamethasone—multiple sclerosis	0.000285	0.000765	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000284	0.000763	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000283	0.00076	CcSEcCtD
Lercanidipine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000282	0.000759	CcSEcCtD
Lercanidipine—Paraesthesia—Betamethasone—multiple sclerosis	0.000282	0.000759	CcSEcCtD
Lercanidipine—Discomfort—Prednisone—multiple sclerosis	0.000282	0.000759	CcSEcCtD
Lercanidipine—Mental disorder—Methotrexate—multiple sclerosis	0.000282	0.000759	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—multiple sclerosis	0.000281	0.000754	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—multiple sclerosis	0.000281	0.000754	CcSEcCtD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000279	0.0135	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000278	0.000747	CcSEcCtD
Lercanidipine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000277	0.000744	CcSEcCtD
Lercanidipine—Dyspepsia—Betamethasone—multiple sclerosis	0.000277	0.000744	CcSEcCtD
Lercanidipine—Urticaria—Triamcinolone—multiple sclerosis	0.000275	0.00074	CcSEcCtD
Lercanidipine—Urticaria—Methylprednisolone—multiple sclerosis	0.000275	0.000739	CcSEcCtD
Lercanidipine—Dysgeusia—Methotrexate—multiple sclerosis	0.000275	0.000738	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—TNFRSF1A—multiple sclerosis	0.000274	0.0133	CbGpPWpGaD
Lercanidipine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000274	0.000737	CcSEcCtD
Lercanidipine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000273	0.000735	CcSEcCtD
Lercanidipine—Decreased appetite—Betamethasone—multiple sclerosis	0.000273	0.000735	CcSEcCtD
Lercanidipine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000273	0.000735	CcSEcCtD
Lercanidipine—Nausea—Mitoxantrone—multiple sclerosis	0.000273	0.000734	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000272	0.00073	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000272	0.00073	CcSEcCtD
Lercanidipine—Fatigue—Betamethasone—multiple sclerosis	0.000271	0.000729	CcSEcCtD
Lercanidipine—Fatigue—Dexamethasone—multiple sclerosis	0.000271	0.000729	CcSEcCtD
Lercanidipine—Shock—Prednisone—multiple sclerosis	0.00027	0.000724	CcSEcCtD
Lercanidipine—Nervous system disorder—Prednisone—multiple sclerosis	0.000269	0.000722	CcSEcCtD
Lercanidipine—Tachycardia—Prednisone—multiple sclerosis	0.000267	0.000719	CcSEcCtD
Lercanidipine—Skin disorder—Prednisone—multiple sclerosis	0.000266	0.000715	CcSEcCtD
Lercanidipine—CACNA1D—Developmental Biology—CD24—multiple sclerosis	0.000266	0.0128	CbGpPWpGaD
Lercanidipine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000265	0.000712	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—multiple sclerosis	0.000264	0.000711	CcSEcCtD
Lercanidipine—Anorexia—Prednisone—multiple sclerosis	0.000261	0.000702	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00026	0.0007	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00026	0.0125	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00026	0.0125	CbGpPWpGaD
Lercanidipine—Anaemia—Methotrexate—multiple sclerosis	0.000259	0.000697	CcSEcCtD
Lercanidipine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000259	0.000697	CcSEcCtD
Lercanidipine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000259	0.000697	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000257	0.000691	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000257	0.000691	CcSEcCtD
Lercanidipine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000255	0.000687	CcSEcCtD
Lercanidipine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000255	0.000685	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.000254	0.0123	CbGpPWpGaD
Lercanidipine—Malaise—Methotrexate—multiple sclerosis	0.000253	0.00068	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—multiple sclerosis	0.000252	0.000677	CcSEcCtD
Lercanidipine—Urticaria—Dexamethasone—multiple sclerosis	0.00025	0.000672	CcSEcCtD
Lercanidipine—Urticaria—Betamethasone—multiple sclerosis	0.00025	0.000672	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00025	0.000671	CcSEcCtD
Lercanidipine—Dizziness—Prednisolone—multiple sclerosis	0.000249	0.00067	CcSEcCtD
Lercanidipine—Asthenia—Triamcinolone—multiple sclerosis	0.000249	0.000669	CcSEcCtD
Lercanidipine—Body temperature increased—Betamethasone—multiple sclerosis	0.000249	0.000668	CcSEcCtD
Lercanidipine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000249	0.000668	CcSEcCtD
Lercanidipine—Abdominal pain—Betamethasone—multiple sclerosis	0.000249	0.000668	CcSEcCtD
Lercanidipine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000249	0.000668	CcSEcCtD
Lercanidipine—Asthenia—Methylprednisolone—multiple sclerosis	0.000248	0.000667	CcSEcCtD
Lercanidipine—Insomnia—Prednisone—multiple sclerosis	0.000248	0.000666	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisone—multiple sclerosis	0.000246	0.000661	CcSEcCtD
Lercanidipine—Pruritus—Triamcinolone—multiple sclerosis	0.000245	0.000659	CcSEcCtD
Lercanidipine—Cough—Methotrexate—multiple sclerosis	0.000245	0.000658	CcSEcCtD
Lercanidipine—Pruritus—Methylprednisolone—multiple sclerosis	0.000245	0.000658	CcSEcCtD
Lercanidipine—Dyspepsia—Prednisone—multiple sclerosis	0.000241	0.000648	CcSEcCtD
Lercanidipine—CACNA1C—Alzheimers Disease—TNFRSF1A—multiple sclerosis	0.000241	0.0117	CbGpPWpGaD
Lercanidipine—Myalgia—Methotrexate—multiple sclerosis	0.000239	0.000642	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—multiple sclerosis	0.000239	0.000642	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—multiple sclerosis	0.000239	0.000642	CcSEcCtD
Lercanidipine—Decreased appetite—Prednisone—multiple sclerosis	0.000238	0.00064	CcSEcCtD
Lercanidipine—Rash—Prednisolone—multiple sclerosis	0.000238	0.000639	CcSEcCtD
Lercanidipine—Dermatitis—Prednisolone—multiple sclerosis	0.000237	0.000638	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000237	0.000638	CcSEcCtD
Lercanidipine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000237	0.000636	CcSEcCtD
Lercanidipine—Fatigue—Prednisone—multiple sclerosis	0.000236	0.000635	CcSEcCtD
Lercanidipine—Headache—Prednisolone—multiple sclerosis	0.000236	0.000635	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—multiple sclerosis	0.000236	0.000634	CcSEcCtD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000235	0.0113	CbGpPWpGaD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000235	0.0113	CbGpPWpGaD
Lercanidipine—Constipation—Prednisone—multiple sclerosis	0.000234	0.00063	CcSEcCtD
Lercanidipine—CACNA1C—Developmental Biology—CD24—multiple sclerosis	0.000233	0.0113	CbGpPWpGaD
Lercanidipine—Confusional state—Methotrexate—multiple sclerosis	0.000231	0.00062	CcSEcCtD
Lercanidipine—Dizziness—Triamcinolone—multiple sclerosis	0.000229	0.000616	CcSEcCtD
Lercanidipine—Dizziness—Methylprednisolone—multiple sclerosis	0.000229	0.000615	CcSEcCtD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000228	0.011	CbGpPWpGaD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000228	0.011	CbGpPWpGaD
Lercanidipine—Feeling abnormal—Prednisone—multiple sclerosis	0.000226	0.000607	CcSEcCtD
Lercanidipine—Asthenia—Betamethasone—multiple sclerosis	0.000226	0.000607	CcSEcCtD
Lercanidipine—Asthenia—Dexamethasone—multiple sclerosis	0.000226	0.000607	CcSEcCtD
Lercanidipine—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000225	0.0109	CbGpPWpGaD
Lercanidipine—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000225	0.0109	CbGpPWpGaD
Lercanidipine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000225	0.000603	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000224	0.000603	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000224	0.000602	CcSEcCtD
Lercanidipine—Nausea—Prednisolone—multiple sclerosis	0.000224	0.000602	CcSEcCtD
Lercanidipine—Pruritus—Dexamethasone—multiple sclerosis	0.000223	0.000598	CcSEcCtD
Lercanidipine—Pruritus—Betamethasone—multiple sclerosis	0.000223	0.000598	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—multiple sclerosis	0.000222	0.000598	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000221	0.000595	CcSEcCtD
Lercanidipine—Vomiting—Triamcinolone—multiple sclerosis	0.00022	0.000592	CcSEcCtD
Lercanidipine—Vomiting—Methylprednisolone—multiple sclerosis	0.00022	0.000591	CcSEcCtD
Lercanidipine—Rash—Triamcinolone—multiple sclerosis	0.000219	0.000588	CcSEcCtD
Lercanidipine—Dermatitis—Triamcinolone—multiple sclerosis	0.000218	0.000587	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—multiple sclerosis	0.000218	0.000587	CcSEcCtD
Lercanidipine—Rash—Methylprednisolone—multiple sclerosis	0.000218	0.000586	CcSEcCtD
Lercanidipine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000218	0.000586	CcSEcCtD
Lercanidipine—Urticaria—Prednisone—multiple sclerosis	0.000218	0.000585	CcSEcCtD
Lercanidipine—Headache—Triamcinolone—multiple sclerosis	0.000217	0.000584	CcSEcCtD
Lercanidipine—Headache—Methylprednisolone—multiple sclerosis	0.000217	0.000582	CcSEcCtD
Lercanidipine—Abdominal pain—Prednisone—multiple sclerosis	0.000217	0.000582	CcSEcCtD
Lercanidipine—Body temperature increased—Prednisone—multiple sclerosis	0.000217	0.000582	CcSEcCtD
Lercanidipine—Diarrhoea—Betamethasone—multiple sclerosis	0.000215	0.000579	CcSEcCtD
Lercanidipine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000215	0.000579	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—multiple sclerosis	0.000214	0.000575	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000209	0.000561	CcSEcCtD
Lercanidipine—Dizziness—Dexamethasone—multiple sclerosis	0.000208	0.000559	CcSEcCtD
Lercanidipine—Dizziness—Betamethasone—multiple sclerosis	0.000208	0.000559	CcSEcCtD
Lercanidipine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000208	0.01	CbGpPWpGaD
Lercanidipine—Insomnia—Methotrexate—multiple sclerosis	0.000207	0.000557	CcSEcCtD
Lercanidipine—Nausea—Triamcinolone—multiple sclerosis	0.000206	0.000553	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—multiple sclerosis	0.000206	0.000553	CcSEcCtD
Lercanidipine—Nausea—Methylprednisolone—multiple sclerosis	0.000205	0.000552	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—multiple sclerosis	0.000204	0.000549	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—multiple sclerosis	0.000204	0.000547	CcSEcCtD
Lercanidipine—Hypersensitivity—Prednisone—multiple sclerosis	0.000202	0.000542	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—multiple sclerosis	0.000202	0.000542	CcSEcCtD
Lercanidipine—Vomiting—Dexamethasone—multiple sclerosis	0.0002	0.000538	CcSEcCtD
Lercanidipine—Vomiting—Betamethasone—multiple sclerosis	0.0002	0.000538	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—multiple sclerosis	0.000199	0.000535	CcSEcCtD
Lercanidipine—Rash—Betamethasone—multiple sclerosis	0.000198	0.000533	CcSEcCtD
Lercanidipine—Rash—Dexamethasone—multiple sclerosis	0.000198	0.000533	CcSEcCtD
Lercanidipine—Dermatitis—Betamethasone—multiple sclerosis	0.000198	0.000533	CcSEcCtD
Lercanidipine—Dermatitis—Dexamethasone—multiple sclerosis	0.000198	0.000533	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000198	0.000531	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—multiple sclerosis	0.000197	0.000531	CcSEcCtD
Lercanidipine—Headache—Betamethasone—multiple sclerosis	0.000197	0.00053	CcSEcCtD
Lercanidipine—Headache—Dexamethasone—multiple sclerosis	0.000197	0.00053	CcSEcCtD
Lercanidipine—Asthenia—Prednisone—multiple sclerosis	0.000197	0.000528	CcSEcCtD
Lercanidipine—Pruritus—Prednisone—multiple sclerosis	0.000194	0.000521	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.000191	0.00922	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000191	0.00922	CbGpPWpGaD
Lercanidipine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000189	0.000507	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—FAS—multiple sclerosis	0.000189	0.00911	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000188	0.00909	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000188	0.00909	CbGpPWpGaD
Lercanidipine—Diarrhoea—Prednisone—multiple sclerosis	0.000187	0.000504	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000187	0.000503	CcSEcCtD
Lercanidipine—Nausea—Dexamethasone—multiple sclerosis	0.000187	0.000502	CcSEcCtD
Lercanidipine—Nausea—Betamethasone—multiple sclerosis	0.000187	0.000502	CcSEcCtD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000185	0.00892	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000185	0.00892	CbGpPWpGaD
Lercanidipine—Urticaria—Methotrexate—multiple sclerosis	0.000182	0.000489	CcSEcCtD
Lercanidipine—Dizziness—Prednisone—multiple sclerosis	0.000181	0.000487	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—multiple sclerosis	0.000181	0.000486	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—multiple sclerosis	0.000181	0.000486	CcSEcCtD
Lercanidipine—Vomiting—Prednisone—multiple sclerosis	0.000174	0.000468	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—APOE—multiple sclerosis	0.000173	0.00836	CbGpPWpGaD
Lercanidipine—Rash—Prednisone—multiple sclerosis	0.000173	0.000464	CcSEcCtD
Lercanidipine—Dermatitis—Prednisone—multiple sclerosis	0.000173	0.000464	CcSEcCtD
Lercanidipine—Headache—Prednisone—multiple sclerosis	0.000172	0.000461	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000169	0.000453	CcSEcCtD
Lercanidipine—CACNA1C—Alzheimers Disease—FAS—multiple sclerosis	0.000166	0.00801	CbGpPWpGaD
Lercanidipine—Asthenia—Methotrexate—multiple sclerosis	0.000164	0.000442	CcSEcCtD
Lercanidipine—Nausea—Prednisone—multiple sclerosis	0.000163	0.000437	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—multiple sclerosis	0.000162	0.000435	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—multiple sclerosis	0.000157	0.000421	CcSEcCtD
Lercanidipine—CACNA1C—Alzheimers Disease—APOE—multiple sclerosis	0.000152	0.00735	CbGpPWpGaD
Lercanidipine—Dizziness—Methotrexate—multiple sclerosis	0.000151	0.000407	CcSEcCtD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000149	0.0072	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000149	0.0072	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000149	0.0072	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000147	0.0071	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000147	0.0071	CbGpPWpGaD
Lercanidipine—Vomiting—Methotrexate—multiple sclerosis	0.000146	0.000391	CcSEcCtD
Lercanidipine—Rash—Methotrexate—multiple sclerosis	0.000144	0.000388	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—multiple sclerosis	0.000144	0.000388	CcSEcCtD
Lercanidipine—Headache—Methotrexate—multiple sclerosis	0.000143	0.000386	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000138	0.00666	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000138	0.00666	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000136	0.00657	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000136	0.00657	CbGpPWpGaD
Lercanidipine—Nausea—Methotrexate—multiple sclerosis	0.000136	0.000366	CcSEcCtD
Lercanidipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000134	0.00646	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000131	0.00632	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—PRNP—multiple sclerosis	0.000123	0.00593	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000121	0.00583	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000121	0.00583	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—IL1B—multiple sclerosis	0.00011	0.00533	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—PRNP—multiple sclerosis	0.000108	0.00521	CbGpPWpGaD
Lercanidipine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000107	0.00516	CbGpPWpGaD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.97e-05	0.00482	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	9.81e-05	0.00474	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	9.81e-05	0.00474	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—IL1B—multiple sclerosis	9.69e-05	0.00468	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.67e-05	0.00467	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.67e-05	0.00467	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—PTPRC—multiple sclerosis	9.55e-05	0.00461	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	9.48e-05	0.00458	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—PRNP—multiple sclerosis	8.76e-05	0.00423	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—SRM—multiple sclerosis	8.61e-05	0.00416	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—MAPK1—multiple sclerosis	8.41e-05	0.00406	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—PTPRC—multiple sclerosis	8.39e-05	0.00405	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	8.33e-05	0.00402	CbGpPWpGaD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.08e-05	0.0039	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—TNF—multiple sclerosis	8.01e-05	0.00387	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—PRNP—multiple sclerosis	7.7e-05	0.00372	CbGpPWpGaD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	7.68e-05	0.00371	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—SRM—multiple sclerosis	7.56e-05	0.00365	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—MAPK1—multiple sclerosis	7.39e-05	0.00357	CbGpPWpGaD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	7.28e-05	0.00352	CbGpPWpGaD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.21e-05	0.00348	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—TNF—multiple sclerosis	7.03e-05	0.0034	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—PTPRC—multiple sclerosis	6.81e-05	0.00329	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.41e-05	0.0031	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.41e-05	0.0031	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	6.4e-05	0.00309	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.33e-05	0.00306	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.33e-05	0.00306	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP24A1—multiple sclerosis	6.07e-05	0.00293	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP27B1—multiple sclerosis	6.07e-05	0.00293	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—PTPRC—multiple sclerosis	5.99e-05	0.00289	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.84e-05	0.00282	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GPC5—multiple sclerosis	5.55e-05	0.00268	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP27B1—multiple sclerosis	5.33e-05	0.00257	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP24A1—multiple sclerosis	5.33e-05	0.00257	CbGpPWpGaD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.12e-05	0.00248	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GPC5—multiple sclerosis	4.87e-05	0.00236	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SRM—multiple sclerosis	4.63e-05	0.00224	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—RRM1—multiple sclerosis	4.6e-05	0.00222	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—POMC—multiple sclerosis	4.29e-05	0.00207	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—TYK2—multiple sclerosis	4.27e-05	0.00206	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.15e-05	0.00201	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—RRM1—multiple sclerosis	4.04e-05	0.00195	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—TYK2—multiple sclerosis	3.75e-05	0.00181	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—MMP9—multiple sclerosis	3.36e-05	0.00163	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.35e-05	0.00162	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SRM—multiple sclerosis	3.35e-05	0.00162	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	3.26e-05	0.00158	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	3.26e-05	0.00158	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.1e-05	0.0015	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TYK2—multiple sclerosis	3.05e-05	0.00147	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.98e-05	0.00144	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MMP9—multiple sclerosis	2.96e-05	0.00143	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—MAPK1—multiple sclerosis	2.72e-05	0.00131	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.72e-05	0.00131	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TYK2—multiple sclerosis	2.68e-05	0.00129	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—BCHE—multiple sclerosis	2.64e-05	0.00128	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.47e-05	0.00119	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MMP9—multiple sclerosis	2.4e-05	0.00116	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MAPK1—multiple sclerosis	2.39e-05	0.00115	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SRM—multiple sclerosis	2.38e-05	0.00115	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.36e-05	0.00114	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.36e-05	0.00114	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—BCHE—multiple sclerosis	2.32e-05	0.00112	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.21e-05	0.00107	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.16e-05	0.00104	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—STAT3—multiple sclerosis	2.13e-05	0.00103	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MMP9—multiple sclerosis	2.11e-05	0.00102	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—IL6—multiple sclerosis	2.09e-05	0.00101	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TGFB1—multiple sclerosis	1.98e-05	0.000956	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MAPK1—multiple sclerosis	1.94e-05	0.000937	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—STAT3—multiple sclerosis	1.88e-05	0.000906	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TNF—multiple sclerosis	1.85e-05	0.000892	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—IL6—multiple sclerosis	1.84e-05	0.000887	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.79e-05	0.000864	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TGFB1—multiple sclerosis	1.74e-05	0.00084	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MAPK1—multiple sclerosis	1.7e-05	0.000824	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.68e-05	0.00081	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.68e-05	0.00081	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TNF—multiple sclerosis	1.62e-05	0.000784	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—APOE—multiple sclerosis	1.59e-05	0.000767	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.56e-05	0.000752	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.53e-05	0.000741	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—IL6—multiple sclerosis	1.49e-05	0.00072	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.44e-05	0.000697	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.42e-05	0.000686	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—APOE—multiple sclerosis	1.4e-05	0.000674	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—POMC—multiple sclerosis	1.36e-05	0.000659	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—IL6—multiple sclerosis	1.31e-05	0.000633	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.27e-05	0.000614	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ALB—multiple sclerosis	1.24e-05	0.000601	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—POMC—multiple sclerosis	1.2e-05	0.000579	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.1e-05	0.00053	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.1e-05	0.00053	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALB—multiple sclerosis	1.09e-05	0.000528	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.03e-05	0.000496	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1e-05	0.000485	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—APOE—multiple sclerosis	8.55e-06	0.000413	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.31e-06	0.000402	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—POMC—multiple sclerosis	7.34e-06	0.000355	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.3e-06	0.000353	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALB—multiple sclerosis	6.69e-06	0.000323	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—APOE—multiple sclerosis	6.18e-06	0.000298	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—POMC—multiple sclerosis	5.31e-06	0.000256	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALB—multiple sclerosis	4.84e-06	0.000234	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.77e-06	0.000231	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—APOE—multiple sclerosis	4.39e-06	0.000212	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—POMC—multiple sclerosis	3.77e-06	0.000182	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALB—multiple sclerosis	3.44e-06	0.000166	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—APOE—multiple sclerosis	2.87e-06	0.000139	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.47e-06	0.000119	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.25e-06	0.000109	CbGpPWpGaD
